G-protein Coupled Receptors (GPCRs): A Potential Target of Apigenin as a Novel hACE2 Receptor Specific Therapeutic for Impeding Lung Cancer Considering a Group of Missense and Nonsense Mutations in COVID-19 Patients. European Journal of Pharmaceutical Research, [S. l.], v. 5, n. 1, p. 6–15, 2025. DOI: 10.24018/ejpharma.2025.5.1.85. Disponível em: https://www.ej-pharma.org/index.php/pharma/article/view/85. Acesso em: 18 oct. 2025.